Skip to content

4Accepted Sep 11, 4:08 PM ET

Anterix (ATEX) Director Leslie B. Daniels Sells 2,500 Shares

ATEXAnterix Inc.

Accepted (ET)

4:08 PM

Sep 11, 2026

Filed

Sep 11, 2026

Documents

1

Size

6.8 KB

Summary

Anterix (ATEX) Director Leslie B. Daniels Sells 2,500 Shares

Updated

What Happened Leslie B. Daniels, a director of Anterix Inc. (ATEX), sold 2,500 shares in an open-market transaction on September 10, 2026. The filing reports a weighted-average price of $83.83 per share for total proceeds of $209,575. This was a sale (disposition), which is often a routine liquidity event and not necessarily a signal about the insider’s view of the company.

Key Details

  • Transaction date: 2026-09-10 (reported on Form 4 filed 2026-09-11).
  • Transaction type/code: Sale (S).
  • Shares sold: 2,500; weighted-average price: $83.83; total value: $209,575.
  • Price range: Report footnote states multiple trades occurred at prices from $84.25 down to $83.55; the $83.83 figure is a weighted average. The reporting person has offered to provide a per-price breakdown on request.
  • Shares owned after the transaction: Not specified in the provided summary of the filing.
  • Filing timeliness: Reported the day after the transaction (no late-filing indication in the summary).

Context

  • Sales by non-10% insiders (directors/executives) are common and can reflect personal liquidity needs, portfolio management, or other reasons; filings are factual and do not explain motivation.
  • No indication in the provided filing summary of a 10b5-1 plan, option exercise, gift, or tax-withholding related to this transaction.

AI-written summary · check the filing